University of British Columbia
Inducing neuroblastoma cell death with CD47 and GD2 antibodies
Abstract
dc:descriptionNeuroblastoma is the most common extracranial solid tumour in pediatric patients. Although current therapies have improved outcomes for high-risk cases, the five-year survival rates still remain around 50%. Neuroblastoma cells often express GD2 and CD47 surface markers. While therapies targeting these markers primarily work through immune-mediated mechanisms, emerging evidence suggests that anti-GD2 and anti-CD47 treatments can also induce cell death independently of immune cells. This study utilizes loss- and gain-of-function strategies to examine the direct effects of anti-CD47 and anti-GD2 antibodies on inducing neuroblastoma cell death, either individually or in combination. My results demonstrate that both anti-CD47 and anti-GD2 antibodies induce significant cell death, as assayed by flow cytometry using cell death reporters, in the absence of immune cells. Using CD47 and GD2 knockouts (CRISPR-Cas9-generated), I observed that antibody-mediated cell death depends on specific receptor engagement. Additionally, Western blot and caspase-Glo assays revealed that the cell death occurs without caspase 3/7 activation, indicating involvement of non-canonical cell death pathways. Notably, combining anti-CD47 and anti-GD2 treatments produces an additive effect on cell death, suggesting that they activate distinct signalling pathways. Moreover, baseline GD2 cell-surface levels are positively correlated with cell death rates, suggesting a GD2 "threshold" is required to trigger cell death. To address low target expression, the EZH2-inhibitor tazemetostat was successfully employed to upregulate surface GD2 levels, thereby sensitizing cells to anti-GD2 treatment. These findings enhance our understanding of antibody signalling and contribute to the development of targeted therapies that can effectively bypass immunosuppression, ultimately improving patient outcomes.
Degree
thesis:*- Name thesis:degree_name
- Master of Science - MSc
- Level thesis:degree_level
- master's
- Discipline thesis:degree_discipline
- Interdisciplinary Oncology
- Grantor dc:publisher
- University of British Columbia
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Freitas Vieira, Juliana Maira
- Contributors dc:contributor
-
- Lim, Chinten James
Rights
dc:rights- Statement dc:rights
-
- Attribution-ShareAlike 4.0 International
- Language dc:language
- eng
Identifiers
dc:identifier.*- Handle dc:identifier
- http://hdl.handle.net/2429/95194